Atopic Dermatitis Clinical Trials in Las Vegas, Nevada
4 studies are recruiting for atopic dermatitis in Las Vegas, Nevada right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic dia…
- Stage
- Not phased
- Ages
- 12 to 89
- Site
- Las Vegas Dermatology, Las Vegas, Nevada
- Locations
- 10 in total
- Run by
- Castle Biosciences Incorporated
-
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. …
- Stage
- Not phased
- Ages
- 12 and older
- Site
- Las Vegas Dermatology- Site Number : 8400002, Las Vegas, Nevada
- Locations
- 79 in total
- Run by
- Sanofi
-
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy an…
- Stage
- Phase 3
- Ages
- 18 to 63
- Site
- Las Vegas Dermatology /ID# 265801, Las Vegas, Nevada
- Locations
- 128 in total
- Run by
- AbbVie
-
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.
- Stage
- Not phased
- Ages
- 12 and older
- Site
- Galderma Investigational Site 8848, Las Vegas, Nevada
- Locations
- 108 in total
- Run by
- Galderma R&D
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.